- Home
- ZKIN vs BOLT Comparison
ZKIN vs BOLT Comparison
Compare ZKIN & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZKIN
- BOLT
- Stock Information
- Founded
- ZKIN 2015
- BOLT 2015
- Country
- ZKIN China
- BOLT United States
- Employees
- ZKIN N/A
- BOLT N/A
- Industry
- ZKIN Metal Fabrications
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- ZKIN Industrials
- BOLT Health Care
- Exchange
- ZKIN Nasdaq
- BOLT Nasdaq
- Market Cap
- ZKIN 9.9M
- BOLT 9.4M
- IPO Year
- ZKIN 2017
- BOLT 2021
- Fundamental
- Price
- ZKIN $1.85
- BOLT $5.19
- Analyst Decision
- ZKIN
- BOLT Buy
- Analyst Count
- ZKIN 0
- BOLT 3
- Target Price
- ZKIN N/A
- BOLT $47.50
- AVG Volume (30 Days)
- ZKIN 27.1K
- BOLT 14.4K
- Earning Date
- ZKIN 09-29-2025
- BOLT 08-14-2025
- Dividend Yield
- ZKIN N/A
- BOLT N/A
- EPS Growth
- ZKIN N/A
- BOLT N/A
- EPS
- ZKIN N/A
- BOLT N/A
- Revenue
- ZKIN $108,199,877.00
- BOLT $4,167,000.00
- Revenue This Year
- ZKIN N/A
- BOLT N/A
- Revenue Next Year
- ZKIN N/A
- BOLT N/A
- P/E Ratio
- ZKIN N/A
- BOLT N/A
- Revenue Growth
- ZKIN N/A
- BOLT N/A
- 52 Week Low
- ZKIN $0.82
- BOLT $4.59
- 52 Week High
- ZKIN $6.30
- BOLT $14.36
- Technical
- Relative Strength Index (RSI)
- ZKIN 42.21
- BOLT 46.64
- Support Level
- ZKIN $1.86
- BOLT $4.81
- Resistance Level
- ZKIN $2.09
- BOLT $5.28
- Average True Range (ATR)
- ZKIN 0.15
- BOLT 0.26
- MACD
- ZKIN 0.01
- BOLT 0.01
- Stochastic Oscillator
- ZKIN 31.53
- BOLT 70.26
About ZKIN ZK International Group Co. Ltd
ZK International Group Co Ltd is engaged in the manufacture and marketing of metal pipes. The company is specialized in producing double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, single-press tubes and fittings, and stainless-steel strips. The products are used in restaurants, hotels, hospitals, firefighting, food, beverage, ships, engines, industrial seawater desalination and systems of direct-drinking water, cold /hot water supply, city water supply, and gas of large/middle scale construction projects.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.